ANI PHARMACEUTICALS, INC Public Float
ANI PHARMACEUTICALS, INC (ANIP) had Public Float of $1.30 billion as of 2025-06-30, per its 10-K filed 2026-02-27.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-02-27
- 2025-06-30: Entity Public Float $1.30B.
- 2024-06-28: Entity Public Float $1.20B.
- 2023-06-30: Entity Public Float $824.20M.
- 2022-06-30: Entity Public Float $372.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.30B 10-K · filed 2026-02-27 |
| 2024-06-28 | $1.20B 10-K · filed 2025-02-28 |
| 2023-06-30 | $824.20M 10-K · filed 2024-02-29 |
| 2022-06-30 | $372.90M 10-K · filed 2023-03-09 |
| 2021-06-30 | $348.20M 10-K · filed 2022-03-15 |
| 2020-06-30 | $316.10M 10-K · filed 2021-03-11 |
| 2019-06-30 | $657.70M 10-K · filed 2020-02-27 |
| 2018-06-30 | $609.30M 10-K · filed 2019-02-27 |
| 2017-06-30 | $402.90M 10-K · filed 2018-02-27 |
| 2016-06-30 | $475.90M 10-K · filed 2017-03-02 |
| 2015-06-30 | $526.80M 10-K · filed 2016-02-23 |
| 2014-06-30 | $263.20M 10-K · filed 2015-02-23 |
| 2013-06-28 | $36.80M 10-K · filed 2014-02-28 |
| 2012-06-30 | $50.10M 10-K · filed 2013-02-28 |
| 2011-06-30 | $249.90M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |